Dr Reddy's Laboratories Limited develops and manufactures generic medicines, biosimilars, and novel molecules for distribution across 83 countries. The company employs over 26,000 people and operates state-of-the-art facilities and comprehensive research and development centres across its global footprint.
The company's mission centres on accelerating access to affordable and innovative medicines. It targets touching 1.5 billion patient lives by 2030, reflecting a patient-centric approach that views pharmaceutical solutions as pathways to healthier outcomes. Operations span generics, biosimilars, novel molecules, and broader pharmaceutical research and development.
The organisational culture emphasises integrity, respect, collaboration, transparency, and inclusivity. The company treats quality as pervasive rather than a mere compliance function, and maintains an environment that balances scientific rigour with empathy. Leadership expects individual accountability alongside teamwork, and supports continuous learning. Employees work across diverse technical specialisms united by a shared commitment to improving patient health.
